Clinical Trials
22 trialsNCT05007106 2025-08-14
KEYVIBE-005
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT03314935 2025-08-12
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
Incyte Corporation
Phase 1/2 Completed
NCT02009449 2024-11-15
IVY
Eli Lilly and Company
Phase 1 Completed
NCT03287375 2022-10-07
PIPAC-OPC2
Odense University Hospital
Phase 2 Completed
NCT02833753 2022-05-31
Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI
University of Massachusetts, Worcester
Phase 1 Completed
NCT02231086 2021-09-16
COLOPEC
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 3 Completed
NCT02604784 2020-09-17
PI-CaP
Fondazione del Piemonte per l'Oncologia
Phase 1/2 Completed
NCT02658214 2020-08-20
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
AstraZeneca
Phase 1 Completed
NCT01504256 2018-01-23
CatuNeo
AIO-Studien-gGmbH
Phase 2 Completed
NCT02320448 2017-09-12
Treating Peritoneal Carcinomatosis With PIPAC
Odense University Hospital
Phase 2 Completed
NCT03034850 2017-01-27
Thrombin Generation and Platelet Activation in CRS/HIPEC
Ziekenhuis Oost-Limburg
Completed
NCT00769405 2016-08-30
Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer
UNICANCER
Phase 3 Completed
NCT00057863 2015-11-17
Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01481701 2014-10-15
A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma
Jules Bordet Institute
Phase 2 Completed
NCT00071929 2013-06-24
Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00005836 2013-06-21
Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy
National Cancer Institute (NCI)
Phase 2 Completed
NCT00005837 2013-06-21
Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00091182 2013-06-05
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
National Cancer Institute (NCI)
Phase 2 Completed
NCT00296816 2012-08-23
TEACO
Sanofi
Phase 2 Completed
NCT00005860 2011-04-26
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum
National Cancer Institute (NCI)
Phase 1 Completed
NCT00006391 2011-04-05
Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
NYU Langone Health
Phase 1 Completed
NCT00612495 2008-02-11
Endometrial Cancer - LOHP Alone and With 5FU
Sanofi
Phase 2 Completed